<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01465789</url>
  </required_header>
  <id_info>
    <org_study_id>BCS 102.2</org_study_id>
    <nct_id>NCT01465789</nct_id>
  </id_info>
  <brief_title>Noninvasive Biomarkers for Monitoring Cardiometabolic Risk in Children</brief_title>
  <official_title>Noninvasive Biomarkers for Monitoring Cardiometabolic Risk in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West Virginia School of Osteopathic Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West Virginia School of Osteopathic Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify salivary biomarkers for monitoring cardiometabolic&#xD;
      risk in children. The study hypothesis is that a combination of salivary biomarkers will&#xD;
      predict the presence of risk factors including impaired fasting glucose, hypertension and&#xD;
      dyslipidemia and will reflect changes in these risk factors over time.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Loss of participants to follow-up&#xD;
  </why_stopped>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation (R values) of salivary biomarkers with blood pressure percentile and serum glucose, HDL, total cholesterol, triglyceride and insulin levels in children</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Predictive utility (C-statistic) of salivary biomarkers for development of metabolic syndrome during childhood and adolescence</measure>
    <time_frame>final assessment at age 18 (up to 14 years depending on age of enrollment)</time_frame>
  </primary_outcome>
  <enrollment type="Actual">33</enrollment>
  <condition>Obesity</condition>
  <condition>Metabolic Syndrome</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      saliva&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children participating in the CARDIAC Boot Camp program at the Robert C. Byrd Clinic in&#xD;
        Lewisburg WV&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participating in the CARDIAC Boot Camp Program&#xD;
&#xD;
          -  Between the ages of 4 and 17&#xD;
&#xD;
          -  Parental permission&#xD;
&#xD;
          -  Ability to provide assent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to comply with saliva collection procedures&#xD;
&#xD;
          -  Renal insufficiency or juvenile gout&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristie G Bridges, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>West Virginia School of Osteopathic Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jill Cochran, PhD, MSN, RN-C FNP</last_name>
    <role>Principal Investigator</role>
    <affiliation>West Virginia School of Osteopathic Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>West Virginia School of Osteopathic Medicine</name>
      <address>
        <city>Lewisburg</city>
        <state>West Virginia</state>
        <zip>24901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <study_first_submitted>July 5, 2011</study_first_submitted>
  <study_first_submitted_qc>November 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2011</study_first_posted>
  <last_update_submitted>August 5, 2013</last_update_submitted>
  <last_update_submitted_qc>August 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West Virginia School of Osteopathic Medicine</investigator_affiliation>
    <investigator_full_name>Kristie Bridges</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

